VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JRVR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JRVRJames River Group Holdings, Ltd.
$4.45$205M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJRVRQuarterly Financials

James River Group Holdings, Ltd. (JRVR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

James River Group Holdings, Ltd. (JRVR) quarterly income statement — complete revenue, gross profit & net income history

JRVR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue151.38M167.75M172.74M174.84M172.29M126.71M191.5M188.29M201.13M116.86M210.32M194.78M191.73M225.71M201.23M184.81M201.95M207.34M190.99M191.57M
Revenue Growth %-12.13%32.38%-9.8%-7.14%-14.34%8.43%-8.95%-3.33%4.9%-48.23%4.52%5.4%-5.06%8.86%5.36%-3.53%10.37%6.77%7.62%2.58%
Medical Costs & Claims108.16M108.75M136.29M130.54M117.06M160.3M51.31M129.24M128.09M55.87M139.49M140.37M143.21M154.08M176.3M144.56M158.44M247.61M186.03M133.4M
Medical Cost Ratio %71.45%64.83%78.9%74.66%67.95%126.51%26.8%68.64%63.69%47.81%66.32%72.07%74.69%68.26%87.61%78.22%78.46%119.42%97.4%69.64%
Gross Profit43.22M58.99M36.45M44.31M55.22M-33.59M140.18M59.05M73.04M60.99M70.83M54.41M48.52M71.63M24.93M40.25M43.5M-40.27M4.96M58.16M
Gross Margin %28.55%35.17%21.1%25.34%32.05%-26.51%73.2%31.36%36.31%52.19%33.68%27.93%25.31%31.74%12.39%21.78%21.54%-19.42%2.6%30.36%
Gross Profit Growth %-21.73%275.63%-74%-24.97%-24.39%-155.07%97.91%8.53%50.52%-14.86%184.18%35.19%11.54%277.9%402.12%-30.8%138.84%-1051.71%-90.92%-12.37%
Operating Expenses53.86M34.44M33.79M36.98M39.22M38.69M178.26M38.86M40.08M32.08M40.1M36.57M37.48M41.42M29.54M29.99M29.98M26.12M26.27M25.68M
OpEx / Revenue %35.58%20.53%19.56%21.15%22.76%30.53%93.09%20.64%19.93%27.45%19.06%18.78%19.55%18.35%14.68%16.23%14.84%12.6%13.75%13.41%
Depreciation & Amortization521K91K90K91K91K91K90K91K91K91K90K91K91K91K90K91K91K91K90K91K
Combined Ratio %107.03%85.36%98.46%95.81%90.71%157.04%119.88%89.28%83.61%75.26%85.39%90.84%94.24%86.62%102.29%94.45%93.3%132.02%111.15%83.04%
Operating Income-10.63M24.55M2.65M7.33M16.01M-72.28M-38.08M20.19M32.96M28.91M30.73M17.84M11.04M30.21M-4.61M10.26M13.53M-66.39M-21.3M32.48M
Operating Margin %-7.03%14.64%1.54%4.19%9.29%-57.04%-19.88%10.72%16.39%24.74%14.61%9.16%5.76%13.38%-2.29%5.55%6.7%-32.02%-11.15%16.96%
Operating Income Growth %-166.43%133.97%106.96%-63.71%-51.43%-349.98%-223.89%13.18%198.55%-4.3%766.27%73.84%-18.39%145.51%78.34%-68.41%109.61%-282.57%-169.28%-18.3%
EBITDA-10.11M24.65M2.74M7.42M16.1M-72.19M-37.99M20.28M33.05M29M30.82M17.93M11.13M30.3M-4.52M10.35M13.62M-66.3M-21.21M32.57M
EBITDA Margin %-6.68%14.69%1.59%4.24%9.34%-56.97%-19.84%10.77%16.43%24.82%14.66%9.2%5.81%13.43%-2.25%5.6%6.74%-31.97%-11.11%17%
Interest Expense5.59M5.97M6.22M5.8M5.54M5.71M6.13M6.34M6.49M5.71M7.33M6M5.58M6.29M4.95M4.05M2.29M2.23M2.23M2.25M
Non-Operating Income0-5.97M-6.22M-5.8M-5.54M-5.71M7.79M-6.34M-6.49M-3.74M-6.49M-6M-5.58M-6.29M-4.95M-4.05M-2.29M-2.23M-2.23M-2.25M
Pretax Income-10.63M24.55M2.65M7.33M16.01M-72.28M-51.99M20.19M32.96M28.91M30.73M17.84M11.04M30.21M-4.61M10.26M13.53M-66.39M-21.3M32.48M
Pretax Margin %-7.03%14.64%1.54%4.19%9.29%-57.04%-27.15%10.72%16.39%24.74%14.61%9.16%5.76%13.38%-2.29%5.55%6.7%-32.02%-11.15%16.96%
Income Tax-1.86M-7.56M1.06M2.21M5.02M-8.88M-13.91M5.71M9.45M10.18M7.01M5.71M3.14M12.49M8K2.6M3.32M-94K2.59M11.64M
Effective Tax Rate %17.5%-30.8%39.93%30.12%31.36%12.29%26.76%28.29%28.68%35.19%22.82%32%28.41%41.33%-0.17%25.31%24.56%0.14%-12.15%35.83%
Net Income-8.92M32.07M1.02M4.76M9.57M-64.77M-39.38M7.63M15.4M-150.16M19.55M15.91M9.61M17.73M-4.62M7.66M10.21M-66.29M-23.89M20.84M
Net Margin %-5.89%19.12%0.59%2.72%5.56%-51.11%-20.56%4.05%7.66%-128.49%9.3%8.17%5.01%7.85%-2.3%4.15%5.05%-31.97%-12.51%10.88%
Net Income Growth %-193.2%149.52%102.59%-37.59%-37.84%56.87%-301.43%-52.09%60.31%-947.14%523.09%107.65%-5.85%126.74%80.66%-63.23%109.86%-227.24%-190.89%-41.48%
EPS (Diluted)-0.230.50-0.020.060.13-2.25-1.100.130.29-4.060.450.350.250.40-0.120.130.27-1.78-0.640.60
EPS Growth %-276.92%122.22%98.13%-53.85%-55.17%44.58%-344.44%-62.86%16%-1115%475%169.23%-7.41%122.47%81.25%-78.33%108.01%-169.7%-175.29%-48.28%
EPS (Basic)-0.230.65-0.020.060.17-2.25-1.110.130.34-4.060.450.350.260.40-0.120.130.27-1.78-0.640.61
Diluted Shares Outstanding46.1M60.11M46.46M46.43M59.66M41.24M37.88M38.04M44.64M37.66M37.82M37.86M37.79M37.68M37.45M37.73M37.55M37.32M37.28M34.59M